CLINICAL_TRIALS
research
· 2009-01-16
Clinical Trial Update: Study to Evaluate the Effect of Renal Function on the Single-Dose Pharmacokinetics of BAY 43-9006 [Phase 1]
Summary
Phase 1 study evaluating the effect of renal function on the single-dose pharmacokinetics of BAY 43-9006 (sorafenib).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Kidney Diseases | Phase 1 | Status: COMPLETED